Company Filing History:
Years Active: 2018
Title: Hyun Joo: Innovator in Synthetic Antibody Mimic Peptides
Introduction
Hyun Joo is a prominent inventor based in Stockton, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic antibody mimic peptides. His innovative work has the potential to impact various therapeutic applications.
Latest Patents
Hyun Joo holds 1 patent for his invention titled "Synthetic antibody mimic peptides." This patent relates to compositions and methods that include peptide molecules designed to mimic the binding and functional properties of native antibodies. The invention encompasses peptide-drug conjugates (PDCs) that utilize these mimic peptides. The targets for these peptides include critical proteins such as epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), vascular endothelial growth factor (VEGF), programmed cell death protein 1 (PD-1), and programmed death-ligand 1 (PD-L1). His work employs the knob-socket computational model to design effective antibody mimics for proteins.
Career Highlights
Hyun Joo is associated with Formurex, Inc., where he continues to advance his research and development efforts. His expertise in synthetic peptides has positioned him as a valuable asset in the biotechnology sector.
Collaborations
Hyun Joo collaborates with notable colleagues, including Xiaoling Li and Jerry Tsai. Their combined efforts contribute to the innovative research environment at Formurex, Inc.
Conclusion
Hyun Joo's work in synthetic antibody mimic peptides showcases his dedication to advancing biotechnology. His innovative approaches have the potential to lead to significant breakthroughs in therapeutic applications.